Opportunity ID: 299528

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-18-025
Funding Opportunity Title: Consequences of amyloid protein polymorphisms in Alzheimer’s disease (R01 – Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 18, 2017
Last Updated Date:
Original Closing Date for Applications: Mar 28, 2018
Current Closing Date for Applications: Mar 28, 2018
Archive Date: May 03, 2018
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Special district governments
Public housing authorities/Indian housing authorities
City or township governments
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites innovative research focused on understanding the consequences of amyloid protein polymorphism in regulation and initiation of early pathogenesis in Alzheimers disease (AD). Specifically, this FOA encourages collaborative approaches designed to identify and characterize the regulation of biochemical and cellular pathways that are responsible for the differential accumulation of various protein conformers in AD clinical subtypes.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-025.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or after January 25, 2018 PKG00237149 Feb 26, 2018 Mar 28, 2018 View

Package 1

Mandatory forms

299528 RR_SF424_2_0-2.0.pdf

299528 PHS398_CoverPageSupplement_4_0-4.0.pdf

299528 RR_OtherProjectInfo_1_4-1.4.pdf

299528 PerformanceSite_2_0-2.0.pdf

299528 RR_KeyPersonExpanded_2_0-2.0.pdf

299528 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

299528 RR_Budget_1_4-1.4.pdf

299528 RR_SubawardBudget30_1_4-1.4.pdf

299528 PHS398_ModularBudget_1_2-1.2.pdf

299528 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T08:48:02-05:00

Share This Post, Choose Your Platform!

About the Author: